Drug
T-900607 sodium clinical trials
A product of T 900607; its studies count on that page too.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2002
How studies write it
Studies that test it under each name
Name
- intravenous T900607-sodium
- 3
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Related medicines
As reviewed, each with the page that says it.
- A salt or form of T 900607
Studies
Open first, then newest update. How each study uses t-900607 sodium is read from its arms, and is right about nine times in ten.
Testing it · 4
- Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the EsophagusSuspendedPhase 2TularikNCT00048529Written as T900607-sodium intravenous
- Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.TerminatedPhase 2TularikNCT00043459Written as intravenous T900607-sodium
- Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.Status unknownPhase 2TularikNCT00043446Written as intravenous T900607-sodium
- Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.Status unknownPhase 2TularikNCT00043433Written as intravenous T900607-sodium
Codes
What other systems call t-900607 sodium · ClinicalTrials.gg INT014894
- Wikidata Q27259988t-900607 sodiumOne source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27259988 | t-900607 sodium | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.